CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 200 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $158,987 | +160.6% | 7,828 | +183.2% | 0.00% | – |
Q2 2021 | $61,000 | -30.7% | 2,764 | -62.8% | 0.00% | -100.0% |
Q1 2020 | $88,000 | -70.0% | 7,437 | -64.1% | 0.00% | -50.0% |
Q3 2019 | $293,000 | -40.4% | 20,701 | -50.6% | 0.00% | -60.0% |
Q1 2019 | $492,000 | +53.8% | 41,937 | +115.8% | 0.01% | +66.7% |
Q1 2018 | $320,000 | +290.2% | 19,429 | +180.5% | 0.00% | +200.0% |
Q2 2017 | $82,000 | +95.2% | 6,926 | -10.0% | 0.00% | – |
Q2 2016 | $42,000 | -27.6% | 7,699 | -37.4% | 0.00% | -100.0% |
Q1 2016 | $58,000 | +87.1% | 12,304 | +95.2% | 0.00% | – |
Q4 2015 | $31,000 | +3000.0% | 6,304 | +1776.2% | 0.00% | – |
Q3 2015 | $1,000 | -97.5% | 336 | -94.9% | 0.00% | -100.0% |
Q2 2015 | $40,000 | +73.9% | 6,636 | +61.9% | 0.00% | – |
Q1 2015 | $23,000 | +1050.0% | 4,100 | +485.7% | 0.00% | – |
Q4 2014 | $2,000 | -88.9% | 700 | -89.4% | 0.00% | – |
Q3 2014 | $18,000 | -72.3% | 6,593 | -71.5% | 0.00% | -100.0% |
Q2 2014 | $65,000 | -66.7% | 23,109 | -48.2% | 0.00% | -66.7% |
Q1 2014 | $195,000 | – | 44,638 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,003,723 | $95,164,000 | 6.41% |
TANAKA CAPITAL MANAGEMENT INC | 65,609 | $780,000 | 3.41% |
S&T BANK/PA | 588,620 | $6,999,000 | 1.93% |
Parallel Advisors, LLC | 1,405,895 | $16,716,000 | 1.35% |
Matarin Capital Management, LLC | 623,915 | $7,418,000 | 1.15% |
AJ WEALTH STRATEGIES, LLC | 668,020 | $7,943,000 | 1.08% |
Capital Impact Advisors, LLC | 177,300 | $2,108,000 | 0.88% |
Alambic Investment Management, L.P. | 29,547 | $351,000 | 0.85% |
OXFORD FINANCIAL GROUP, LTD. LLC | 332,436 | $3,953,000 | 0.79% |
Spark Investment Management LLC | 116,400 | $1,383,000 | 0.74% |